Alcon to Buy LumiThera, Photobiomodulation Device for Age-Related Macular Degeneration Treatment-February 2024-www.financetom.com

Alcon to Buy LumiThera, Photobiomodulation Device for Age-Related Macular Degeneration Treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Alcon to Buy LumiThera, Photobiomodulation Device for Age-Related Macular Degeneration Treatment

Jul 7, 2025 6:34 AM

09:10 AM EDT, 07/07/2025 (MT Newswires) -- Alcon ( ALC ) said Monday it intends to buy LumiThera and its Photobiomodulation Device for the treatment of early and intermediate dry age-related macular degeneration - an eye condition that potentially leads to vision loss.

The deal excludes the acquisition of AdaptDx and Nova/Diopsys diagnostic devices, which will be separated and spun-off to LumiThera's stockholders, the company said.

The deal will likely be completed in Q3, Alcon ( ALC ) added.

PBM secured the US Food and Drug Administration's de novo market approval in November and is currently available in Europe, Latin America, Singapore, the UK and the US, the company said.

Previous page： Altria tops quarterly profit estimates, flags $873 million NJOY impairment Next page： SoFi Technologies' Q1 Adjusted Earnings, Revenue Rise; 2025 Guidance Increased

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Altria tops quarterly profit estimates, flags $873 million NJOY impairment

May 25, 2025

April 29 (Reuters) - Tobacco company Altria ( MO ) on Tuesday beat first-quarter profit estimates but flagged an $873 million impairment at its e-cigarette business, where shipments dropped 70% amid a patent dispute. Rising demand for its smoking alternatives, such as on! nicotine pouches and NJOY vapes, helped the company counter the impact from lost cigarette sales as smokers...

SoFi Technologies' Q1 Adjusted Earnings, Revenue Rise; 2025 Guidance Increased

May 25, 2025

08:09 AM EDT, 04/29/2025 (MT Newswires) -- SoFi Technologies ( SOFI ) reported Q1 adjusted net income Tuesday of $0.06 per diluted share, up from $0.02 a year earlier. Analysts polled by FactSet expected $0.03. Total net revenue for the quarter ended March 31 was $771.8 million, up from $645 million a year earlier. Analysts' revenue estimates were not readily...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Incyte Q1 Adjusted Earnings, Revenue Rise

May 25, 2025

08:10 AM EDT, 04/29/2025 (MT Newswires) -- Incyte ( INCY ) reported Q1 adjusted earnings Tuesday of $1.16 per diluted share, up from $0.58 a year earlier. Analysts polled by FactSet expected $0.98. Revenue for the quarter ended March 31 was $1.05 billion, up from $880.9 million a year earlier. Analysts surveyed by FactSet expected $985.1 million. The pharmaceutical company...